CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | Ben Arye Barak General Counsel | Grant or award | +930 | $12.24 | $11K | 118,052 |
| 2024-06-28 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +1,055 | $12.24 | $13K | 252,290 |
| 2024-06-28 | Danziger Asaf Chief Executive Officer | Grant or award | +1,239 | $12.24 | $15K | 15,228 |
| 2024-06-28 | Cordova Ashley Chief Financial Officer | Grant or award | +1,286 | $12.24 | $16K | 220,465 |
| 2024-06-28 | Leonard Frank X EVP, Pres., Novocure Oncology | Grant or award | +1,736 | $12.24 | $21K | 161,834 |
| 2024-06-28 | Puri Michal Nath Chief Human Resources Officer | Grant or award | +1,736 | $12.24 | $21K | 110,903 |
| 2024-06-05 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Exercise or conversion | +124,373 | $22.82 | $2.8M | 124,373 |
| 2024-06-05 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Exercise or conversion · Stock Options (Right to buy) | −124,373 | $22.82 | $2.8M | 95,000 |
| 2024-06-05 | Ocean Allyson J Director | Grant or award | +4,053 | 4,053 | ||
| 2024-06-05 | Ocean Allyson J Director | Grant or award · Stock Options (Right to buy) | +6,229 | 6,229 | ||
| 2024-06-05 | Madden Martin J. Director | Grant or award | +4,053 | 19,673 | ||
| 2024-06-05 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 | ||
| 2024-06-05 | Hung David Director | Grant or award | +4,053 | 13,194 | ||
| 2024-06-05 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 | ||
| 2024-06-05 | Stafford Kristin Director | Grant or award | +4,053 | 4,053 | ||
| 2024-06-05 | Stafford Kristin Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 | ||
| 2024-06-05 | VERNON W ANTHONY Director | Grant or award | +4,053 | 169,850 | ||
| 2024-06-05 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 | ||
| 2024-06-05 | Scannell Timothy J Director | Grant or award | +4,053 | 7,981 | ||
| 2024-06-05 | Scannell Timothy J Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 |
Page 10 of 20 · 399 trades